Health Condition 1: N859- Noninflammatory disorder of uterus, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA 1 and ASA 2 Patients undergoing Laparoscopic Gynaecologic surgeries under general anaesthesia Duration of surgery more than 1 hour and less than 6 hours
Exclusion criteria
Exclusion criteria: Known allergy to study drugs Uncontrolled hepatic or renal disease Patients with cognitive impairmentor unable to do NRS scoring Patients with preexisting ventricular ectopics Patients with preexisting bradycardia (Heart rate <50/Min)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare post operative pain using numeric rating scale in groups receiving dexmedetomidine,lignocaine and fentanyl infusions following laparoscopic gynaecologic surgeries.Timepoint: 1 hour , 4 hour and 24 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 3)To compare post operative analgesic requirements in patients receiving dexmedetomidine ,lignocaine and fentanyl infusions following laparoscopic gynaecologic surgeries.Timepoint: Time to first analgesic requirement Total consumption of tramadol in first 24 hours;To compare post operative recovery using Ramsay sedation score in patients receiving dexmedetomidine ,lignocaine and fentanyl infusions following laparoscopic gynaecologic surgeries.Timepoint: Immediate after reaching Post anaesthesia care room and 1 hour after extubation | — |
Countries
India
Contacts
MOSC Medical College